ad image

Icagen

1 / 1
Enabling Drug Discovery Targeting Ion Channels

Enabling Drug Discovery Targeting Ion Channels

Doug Krafte, Ph.D.

Icagen

Ion ChannelsMay 19, 2022
Icagen
Awards

Icagen Receives Award from the Cystic Fibrosis Foundation to Discover Transformative Therapies to Treat Cystic Fibrosis

Icagen

PR-M05-18-NI-020May 01, 2018
Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics
Innovation

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

Doug Krafte, Ph.D.; Aaron Gerlach, Ph.D.; Neil Castle, Ph.D.

Icagen

PAP-Q4-17-CL-004Oct 26, 2017
Icagen on the Road to BIO: Early-Stage Planning for End-Stage Success
Strategy

Icagen on the Road to BIO: Early-Stage Planning for End-Stage Success

Kenneth F. Wertman, Ph.D.

Icagen

PTV-M06-17-CL-012Jun 22, 2017
Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery
Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Paul R. August; Mark J. Pincus, M.S.

Icagen

PAP-Q2-17-CL-006-5426Jun 05, 2017
Disease in a Dish: Creating Human Tissues In Vitro

Disease in a Dish: Creating Human Tissues In Vitro

Paul R. August

Icagen

PTV-M11-16-AP-014Apr 06, 2017
Integrated Innovation: Fostering the New Growth in Pharma

Integrated Innovation: Fostering the New Growth in Pharma

Anil C. Nair, Ph.D.; Kenneth F. Wertman, Ph.D.; Paul R. August; Marcel Patek, Ph.D.

Icagen

PAP-Q1-17-CL-003Mar 08, 2017
Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches

Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAP-Q04-16-CL-011Oct 01, 2016
1 / 1